{"id":5594,"date":"2017-03-22T08:52:45","date_gmt":"2017-03-22T08:52:45","guid":{"rendered":"http:\/\/demo.themelogi.com\/navian\/?page_id=5594"},"modified":"2021-06-03T23:06:48","modified_gmt":"2021-06-03T23:06:48","slug":"blog-carousel","status":"publish","type":"page","link":"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/blog-carousel\/","title":{"rendered":"Blog RA"},"content":{"rendered":"

[vc_row][vc_column]

\u00daltimas Noticias<\/h5>
<\/div><\/div><\/div><\/div>
\n\t
\n\t\t\n\t\t\t\"BPM \n\t\t<\/a>\n\t<\/div>\n\t
\n\t\tNoticias Asuntos Regulatorios<\/a><\/span><\/span> \n
Invima expide resoluci\u00f3n que aprueba la fabricaci\u00f3n de productos Cosm\u00e9ticos para la Comunidad Andina<\/h5> <\/a>\n
\n
\n
\n
\n <\/figure>\n <\/div>\n
\n
\n RA Asuntos Regulatorios<\/a> junio 23, 2021<\/span> \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\t<\/div>\n<\/div>
\n\t
\n\t\t\n\t\t\t\"\" \n\t\t<\/a>\n\t<\/div>\n\t
\n\t\tNoticias Asuntos Regulatorios<\/a><\/span><\/span> \n
Invima informa que la Decisi\u00f3n Andina 833 de 2018 que regula productos cosm\u00e9ticos, entr\u00f3 en vigencia el 1 de marzo de 202110 Mar 2021<\/h5> <\/a>\n
\n
\n
\n
\n <\/figure>\n <\/div>\n
\n
\n RA Asuntos Regulatorios<\/a> mayo 20, 2021<\/span> \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\t<\/div>\n<\/div>
\n\t
\n\t\t\n\t\t\t\"Tramites \n\t\t<\/a>\n\t<\/div>\n\t
\n\t\tNoticias Asuntos Regulatorios<\/a><\/span><\/span> \n
Invima estandariza, automatiza, mejora procesos, reduce y\/o elimina pagos de sus tr\u00e1mites<\/h5> <\/a>\n
\n
\n
\n
\n <\/figure>\n <\/div>\n
\n
\n RA Asuntos Regulatorios<\/a> mayo 19, 2021<\/span> \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\t<\/div>\n<\/div>
\n\t
\n\t\t\n\t\t\t\"tarjetas \n\t\t<\/a>\n\t<\/div>\n\t
\n\t\tNoticias Asuntos Regulatorios<\/a><\/span><\/span> \n
Advertencia sobre el uso de tarjetas y collares desinfectantes a base de di\u00f3xido de cloro<\/h5> <\/a>\n
\n
\n
\n
\n <\/figure>\n <\/div>\n
\n
\n RA Asuntos Regulatorios<\/a> mayo 18, 2021<\/span> \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\t<\/div>\n<\/div>
\n\t
\n\t\t\n\t\t\t\"\" \n\t\t<\/a>\n\t<\/div>\n\t
\n\t\tNoticias Asuntos Regulatorios<\/a><\/span><\/span> \n
Estado sobre el reporte de eventos adversos presuntamente asociados al uso de la vacuna contra covid-19 desarrollada por AstraZeneca<\/h5> <\/a>\n
\n
\n
\n
\n <\/figure>\n <\/div>\n
\n
\n RA Asuntos Regulatorios<\/a> mayo 18, 2021<\/span> \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\t<\/div>\n<\/div>
\n\t
\n\t\t\n\t\t\t\"\" \n\t\t<\/a>\n\t<\/div>\n\t
\n\t\tNoticias Asuntos Regulatorios<\/a><\/span><\/span> \n
Autorizaciones Sanitarias de Uso de Emergencia – ASUE<\/h5> <\/a>\n
\n
\n
\n
\n <\/figure>\n <\/div>\n
\n
\n RA Asuntos Regulatorios<\/a> mayo 18, 2021<\/span> \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\t<\/div>\n<\/div>
\n\t
\n\t\t\n\t\t\t\"\" \n\t\t<\/a>\n\t<\/div>\n\t
\n\t\tNoticias Asuntos Regulatorios<\/a><\/span><\/span> \n
More flexible storage conditions for BioNTech\/Pfizer\u2019s COVID-19 vaccine<\/h5> <\/a>\n
\n
\n
\n
\n <\/figure>\n <\/div>\n
\n
\n RA Asuntos Regulatorios<\/a> mayo 17, 2021<\/span> \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\t<\/div>\n<\/div>
\n\t
\n\t\t\n\t\t\t\"\" \n\t\t<\/a>\n\t<\/div>\n\t
\n\t\tNoticias Asuntos Regulatorios<\/a><\/span><\/span> \n
Invima estandariza, automatiza, mejora procesos, reduce y\/o elimina pagos de sus tr\u00e1mites<\/h5> <\/a>\n
\n
\n
\n
\n <\/figure>\n <\/div>\n
\n
\n RA Asuntos Regulatorios<\/a> mayo 13, 2021<\/span> \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\t<\/div>\n<\/div><\/div><\/section>[\/vc_column][\/vc_row][vc_row tlg_background_style=\u00bbbg-secondary\u00bb][vc_column]
Ver todos los art\u00edculos<\/h5>
<\/div><\/div><\/div><\/div>
\r\n
\r\n
\r\n \r\n \"\" <\/span>\r\n <\/span>\r\n <\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n \r\n
Invima estandariza, automatiza, mejora procesos, reduce y\/o elimina pagos de sus tr\u00e1mites<\/h5> <\/a>\r\n

Se facilitan y agilizan los tr\u00e1mites a las empresas importadoras y exportadoras. ...<\/p><\/div>\r\n

\r\n Read more<\/a><\/span>\r\n <\/div>\r\n <\/div>\r\n
\r\n
\r\n <\/i>mayo 13, 2021<\/span>\r\n <\/div>\r\n \r\n \t \n\t \t\n\t \t\t<\/i>0 like<\/span><\/span>\t \t<\/a>\n\t <\/span>\n\t <\/span>\r\n <\/div>\r\n <\/div>
\r\n
\r\n
\r\n \r\n \"\" <\/span>\r\n <\/span>\r\n <\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n \r\n
More flexible storage conditions for BioNTech\/Pfizer\u2019s COVID-19 vaccine<\/h5> <\/a>\r\n

More flexible storage conditions for BioNTech\/Pfizer\u2019s COVID-19 vaccine. EMA\u2019s human medicines committee...<\/p><\/div>\r\n

\r\n Read more<\/a><\/span>\r\n <\/div>\r\n <\/div>\r\n
\r\n
\r\n <\/i>mayo 17, 2021<\/span>\r\n <\/div>\r\n \r\n \t \n\t \t\n\t \t\t<\/i>0 like<\/span><\/span>\t \t<\/a>\n\t <\/span>\n\t <\/span>\r\n <\/div>\r\n <\/div>
\r\n
\r\n
\r\n \r\n \"\" <\/span>\r\n <\/span>\r\n <\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n \r\n
Autorizaciones Sanitarias de Uso de Emergencia – ASUE<\/h5> <\/a>\r\n

Ahora podr\u00e1s consultar todo lo necesario para adelantar el tr\u00e1mite de otorgamiento...<\/p><\/div>\r\n

\r\n Read more<\/a><\/span>\r\n <\/div>\r\n <\/div>\r\n
\r\n
\r\n <\/i>mayo 18, 2021<\/span>\r\n <\/div>\r\n \r\n \t \n\t \t\n\t \t\t<\/i>0 like<\/span><\/span>\t \t<\/a>\n\t <\/span>\n\t <\/span>\r\n <\/div>\r\n <\/div>
\r\n
\r\n
\r\n \r\n \"\" <\/span>\r\n <\/span>\r\n <\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n \r\n
Estado sobre el reporte de eventos adversos presuntamente asociados al uso de la vacuna contra covid-19 desarrollada por AstraZeneca<\/h5> <\/a>\r\n

El Instituto Nacional de Vigilancia de Medicamentos y Alimentos \u2013 Invima, informa...<\/p><\/div>\r\n

\r\n Read more<\/a><\/span>\r\n <\/div>\r\n <\/div>\r\n
\r\n
\r\n <\/i>mayo 18, 2021<\/span>\r\n <\/div>\r\n \r\n \t \n\t \t\n\t \t\t<\/i>0 like<\/span><\/span>\t \t<\/a>\n\t <\/span>\n\t <\/span>\r\n <\/div>\r\n <\/div>
\r\n
\r\n
\r\n \r\n \"tarjetas <\/span>\r\n <\/span>\r\n <\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n \r\n
Advertencia sobre el uso de tarjetas y collares desinfectantes a base de di\u00f3xido de cloro<\/h5> <\/a>\r\n

Este tipo de productos no cuenta con Notificaci\u00f3n Sanitaria Obligatoria – NSO,...<\/p><\/div>\r\n

\r\n Read more<\/a><\/span>\r\n <\/div>\r\n <\/div>\r\n
\r\n
\r\n <\/i>mayo 18, 2021<\/span>\r\n <\/div>\r\n \r\n \t \n\t \t\n\t \t\t<\/i>0 like<\/span><\/span>\t \t<\/a>\n\t <\/span>\n\t <\/span>\r\n <\/div>\r\n <\/div>
\r\n
\r\n
\r\n \r\n \"Tramites <\/span>\r\n <\/span>\r\n <\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n \r\n
Invima estandariza, automatiza, mejora procesos, reduce y\/o elimina pagos de sus tr\u00e1mites<\/h5> <\/a>\r\n

Destacamos las acciones de racionalizaci\u00f3n de tr\u00e1mites y otros procedimientos administrativos que...<\/p><\/div>\r\n

\r\n Read more<\/a><\/span>\r\n <\/div>\r\n <\/div>\r\n
\r\n
\r\n <\/i>mayo 19, 2021<\/span>\r\n <\/div>\r\n \r\n \t \n\t \t\n\t \t\t<\/i>0 like<\/span><\/span>\t \t<\/a>\n\t <\/span>\n\t <\/span>\r\n <\/div>\r\n <\/div>
\r\n
\r\n
\r\n \r\n \"\" <\/span>\r\n <\/span>\r\n <\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n \r\n
Invima informa que la Decisi\u00f3n Andina 833 de 2018 que regula productos cosm\u00e9ticos, entr\u00f3 en vigencia el 1 de marzo de 202110 Mar 2021<\/h5> <\/a>\r\n

El Instituto Nacional de Vigilancia de Medicamentos y Alimentos – Invima, a...<\/p><\/div>\r\n

\r\n Read more<\/a><\/span>\r\n <\/div>\r\n <\/div>\r\n
\r\n
\r\n <\/i>mayo 20, 2021<\/span>\r\n <\/div>\r\n \r\n \t \n\t \t\n\t \t\t<\/i>0 like<\/span><\/span>\t \t<\/a>\n\t <\/span>\n\t <\/span>\r\n <\/div>\r\n <\/div>
\r\n
\r\n
\r\n \r\n \"BPM <\/span>\r\n <\/span>\r\n <\/a>\r\n <\/div>\r\n <\/div>\r\n
\r\n \r\n
Invima expide resoluci\u00f3n que aprueba la fabricaci\u00f3n de productos Cosm\u00e9ticos para la Comunidad Andina<\/h5> <\/a>\r\n

El Instituto Nacional de Vigilancia de Medicamentos y Alimentos- Invima, informa a...<\/p><\/div>\r\n

\r\n Read more<\/a><\/span>\r\n <\/div>\r\n <\/div>\r\n
\r\n
\r\n <\/i>junio 23, 2021<\/span>\r\n <\/div>\r\n \r\n \t \n\t \t\n\t \t\t<\/i>0 like<\/span><\/span>\t \t<\/a>\n\t <\/span>\n\t <\/span>\r\n <\/div>\r\n <\/div><\/div><\/section>[\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][\/vc_column][\/vc_row][vc_row tlg_background_style=\u00bbbg-secondary\u00bb][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":8874,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-5594","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nBlog RA - RA ASUNTOS REGULATORIOS S.A.S<\/title>\n<meta name=\"description\" content=\"Blog de Noticias y Actualidad de Asuntos regulatorios y Farmacovigilancia\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/blog-carousel\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Blog de Noticias y Actualidad de Asuntos regulatorios y Farmacovigilancia RA\" \/>\n<meta property=\"og:description\" content=\"Noticias y Actualidad de Asuntos regulatorios y Farmacovigilancia\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/blog-carousel\/\" \/>\n<meta property=\"og:site_name\" content=\"RA ASUNTOS REGULATORIOS S.A.S\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RAAsuntosRegulatorios\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-03T23:06:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-content\/uploads\/2021\/05\/experiencia-en-Asesoria-regulatoria-farmacovigilancia-bogota-colombia-5.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1278\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Blog de Noticias y Actualidad de Asuntos regulatorios y Farmacovigilancia\" \/>\n<meta name=\"twitter:description\" content=\"Blog de Noticias y Actualidad de Asuntos regulatorios y Farmacovigilancia\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-content\/uploads\/2021\/05\/registros-sanitarios-3-colombia.jpg\" \/>\n<meta name=\"twitter:site\" content=\"@regulatorya\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/#organization\",\"name\":\"RA Asuntos regulatorios - Farmacovigilancia\",\"url\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/RAAsuntosRegulatorios\/\",\"https:\/\/www.linkedin.com\/in\/ra-asuntos-regulatorios-b8657817\/\",\"https:\/\/twitter.com\/regulatorya\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/#logo\",\"inLanguage\":\"es\",\"url\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-content\/uploads\/2021\/05\/logo-asuntos-regulatorios-6.png\",\"contentUrl\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-content\/uploads\/2021\/05\/logo-asuntos-regulatorios-6.png\",\"width\":244,\"height\":150,\"caption\":\"RA Asuntos regulatorios - Farmacovigilancia\"},\"image\":{\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/#website\",\"url\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/\",\"name\":\"RA ASUNTOS REGULATORIOS S.A.S\",\"description\":\"Nuestra empresa se especializa en proveer servicios de consultor\\u00eda regulatoria en productos como Medicamentos, Dispositivos M\\u00e9dicos, Equipos biom\\u00e9dicos, Productos Biol\\u00f3gicos, Suplementos Dietarios, Cosm\\u00e9ticos y Productos de Aseo e Higiene Dom\\u00e9stica y alimentos\",\"publisher\":{\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/blog-carousel\/#primaryimage\",\"inLanguage\":\"es\",\"url\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-content\/uploads\/2021\/05\/experiencia-en-Asesoria-regulatoria-farmacovigilancia-bogota-colombia-5.jpg\",\"contentUrl\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-content\/uploads\/2021\/05\/experiencia-en-Asesoria-regulatoria-farmacovigilancia-bogota-colombia-5.jpg\",\"width\":1920,\"height\":1278,\"caption\":\"Asesoria Regulatoria Farmacovigiancia\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/blog-carousel\/#webpage\",\"url\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/blog-carousel\/\",\"name\":\"Blog RA - RA ASUNTOS REGULATORIOS S.A.S\",\"isPartOf\":{\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/blog-carousel\/#primaryimage\"},\"datePublished\":\"2017-03-22T08:52:45+00:00\",\"dateModified\":\"2021-06-03T23:06:48+00:00\",\"description\":\"Blog de Noticias y Actualidad de Asuntos regulatorios y Farmacovigilancia\",\"breadcrumb\":{\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/blog-carousel\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/blog-carousel\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/blog-carousel\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/\",\"url\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/\",\"name\":\"Portada\"}},{\"@type\":\"ListItem\",\"position\":2,\"item\":{\"@id\":\"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/blog-carousel\/#webpage\"}}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-json\/wp\/v2\/pages\/5594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-json\/wp\/v2\/comments?post=5594"}],"version-history":[{"count":7,"href":"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-json\/wp\/v2\/pages\/5594\/revisions"}],"predecessor-version":[{"id":8977,"href":"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-json\/wp\/v2\/pages\/5594\/revisions\/8977"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-json\/wp\/v2\/media\/8874"}],"wp:attachment":[{"href":"https:\/\/www.asuntos-regulatorios.com\/asesoria-regulatoria-farmacovigilancia\/wp-json\/wp\/v2\/media?parent=5594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}